Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer

Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a highly aggressive cancer for which targeted therapeutic agents are limited. Growing evidence suggests that TNBC originates from breast cancer stem cells (BCSCs), and elucidation of the molecular mechanisms controlling BCSC proliferation will be crucial for n...

Full description

Bibliographic Details
Main Authors:	Naoya Hirata, Shigeru Yamada, Shota Yanagida, Atsushi Ono, Yukuto Yasuhiko, Motohiro Nishida, Yasunari Kanda
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	International Journal of Molecular Sciences
Subjects:	lysophosphatidic acid cancer stem cells transient receptor potential cation channel subfamily C member 3 nuclear factor of activated T cells triple-negative breast cancer
Online Access:	https://www.mdpi.com/1422-0067/23/4/1967

Similar Items

Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
by: Yu-Hsuan Lin, et al.
Published: (2021-06-01)

Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers
by: Mahdi Rafiyan, et al.
Published: (2022-06-01)

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
by: C. Chris Yun
Published: (2019-07-01)

Lysophosphatidic Acid Modifies the Response of PC3 Prostate Cancer Cells to Chemotherapeutics
by: G. Esra Genc, et al.
Published: (2020-09-01)

Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
by: Brian De La Franier, et al.
Published: (2020-02-01)

Profiling lysophosphatidic acid levels in plasma from head and neck cancer patients
by: Mariati Abdul Rahman, et al.
Published: (2020-06-01)

Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
by: Pravita Balijepalli, et al.
Published: (2021-08-01)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
by: Sha She, et al.
Published: (2022-06-01)

TAZ Mediates Lysophosphatidic Acid-Induced Migration and Proliferation of Epithelial Ovarian Cancer Cells
by: Geun Ok Jeong, et al.
Published: (2013-07-01)

FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation
by: Naoya Hirata, et al.
Published: (2021-07-01)

Entering, Linked with the Sphinx: Lysophosphatidic Acids Everywhere, All at Once, in the Oral System and Cancer
by: D. Roselyn Cerutis, et al.
Published: (2023-06-01)

Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1
by: Upasana Ray, et al.
Published: (2017-02-01)

Inhibition of TRPM7 suppresses migration and invasion of prostate cancer cells via inactivation of ERK1/2, Src and Akt pathway signaling
by: Eun Hye Lee, et al.
Published: (2022-06-01)

Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases
by: Shufan Jiang, et al.
Published: (2023-08-01)

Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells
by: Christiana Magkrioti, et al.
Published: (2022-07-01)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
by: Bicheng Yang, et al.
Published: (2017-11-01)

Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?
by: Sistiana Aiello, et al.
Published: (2021-06-01)

Lysophosphatidic acid supports the development of vitrified ovarian follicles by decreasing the incidence of cell death: An experimental study
by: Neda Abedpour, et al.
Published: (2022-04-01)

Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
by: Kyung-Jong Won, et al.
Published: (2020-03-01)

Lysophosphatidic acid and itsreceptors: Role in bronchial asthma pathogenesis
by: O. Yu. Kytikova, et al.
Published: (2024-03-01)

Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness
by: Bo Young Jeong, et al.
Published: (2021-05-01)

Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
by: Eunah Shin, et al.
Published: (2019-08-01)

Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid
by: Maria F. Fernandes, et al.
Published: (2022-04-01)

The effect of lysophosphatidic acid-supplemented culture medium on human immature oocytes matured in vitro
by: Qigui Xie, et al.
Published: (2021-06-01)

Lysophosphatidic Acid Receptor 3 Activation Is Involved in the Regulation of Ferroptosis
by: Yi-Xun Huang, et al.
Published: (2024-02-01)

The Effects of Lysophosphatidic Acid on The Incidence of Cell Death in Cultured Vitrified and Non-Vitrified Mouse Ovarian Tissue: Separation of Necrosis and Apoptosis Border
by: Neda Abedpour, et al.
Published: (2018-06-01)

Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure
by: Kun Ding, et al.
Published: (2022-05-01)

Lysophosphatidic acid induces proliferation and osteogenic differentiation of human dental pulp stem cell through lysophosphatidic acid receptor 3/extracellular signal-regulated kinase signaling axis
by: Soon Chul Heo, et al.
Published: (2023-07-01)

Regulation of Tumor Immunity by Lysophosphatidic Acid
by: Sue Chin Lee, et al.
Published: (2020-05-01)

Biofunctionalized Lysophosphatidic Acid/Silk Fibroin Film for Cornea Endothelial Cell Regeneration
by: Joo Hee Choi, et al.
Published: (2018-04-01)

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis
by: Maria Puigdomenech-Poch, et al.
Published: (2021-03-01)

Outcomes Associated With ABCG2 and CD133 Expression in Patients With Gastric Cancer After Surgical Resection
by: Donghoon Kang, et al.
Published: (2023-12-01)

Coupled Electrostatic and Hydrophobic Destabilisation of the Gelsolin-Actin Complex Enables Facile Detection of Ovarian Cancer Biomarker Lysophosphatidic Acid
by: Katharina Davoudian, et al.
Published: (2023-09-01)

Characterization of Native and Human Serum Albumin-Bound Lysophosphatidic Acid Species and Their Effect on the Viability of Mesenchymal Stem Cells In Vitro
by: Aliz Majer, et al.
Published: (2022-08-01)

An ultrathin polydiacetylene nanosheet as dual colorimetric and fluorescent indicator for lysophosphatidic acid, a cancer biomarker
by: Bojian Hu, et al.
Published: (2020-08-01)

RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer in vitro by modulating cathepsin B and MMP9 expression
by: Duk Yoon Kim, et al.
Published: (2021-07-01)

Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
by: Matteo Centonze, et al.
Published: (2023-08-01)

O‐GlcNAcylation regulates lysophosphatidic acid‐induced cell migration by regulating ERM family proteins
by: Minseok Song, et al.
Published: (2022-06-01)

Lysophosphatidic acid stimulates rat uterine contraction in vitro
by: Satoshi NAGASHIMA, et al.
Published: (2023-04-01)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
by: Candide Alioli, et al.
Published: (2022-03-01)